enGene Therapeutics (ENGN) Debt Ratio (2022 - 2026)
enGene Therapeutics' (ENGN) Debt Ratio came in at 0.09 for fiscal Q3 2026 (quarter ended Jul 31, 2026), down 6.6% from 0.09 a year earlier but up 7.7% from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Debt Ratio (2022 - 2026) Analysis & Trends
For FY2025 (ended Oct 31, 2025), enGene Therapeutics' Debt Ratio stood at 0.11, up 41.4% from FY2024.
- In prior fiscal years, enGene Therapeutics' Debt Ratio was 0.07 in FY2024 (-33.8%), 0.11 in FY2023 (-75.4%) and 0.46 in FY2022.
- Quarterly Debt Ratio has run from a low of 0.07 in fiscal Q1 2026 to a high of 0.46 in fiscal Q4 2022 over five years.
- On a year-over-year basis, Debt Ratio has declined in each of the last three quarters, with an average decline of 8.3% over the last eight quarters.
- The strongest year-over-year quarter for Debt Ratio in the past five years was fiscal Q4 2025, with growth of 41.4%; the weakest was fiscal Q4 2023, with a decline of 75.4%.
- According to Business Quant data, Debt Ratio for the three prior fiscal quarters was 0.08 (Q2 2026), 0.07 (Q1 2026) and 0.11 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 0.39 |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 0.23 |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 0.52 |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 0.42 |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 0.08 |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 0.28 |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 0.60 |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 0.53 |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 0.31 |
| 10 | enGene Therapeutics | 104.54 Mn | -889.93 Mn | - | 0.09 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 0.09 |
| Apr 30, 2026 | 0.08 |
| Jan 31, 2026 | 0.07 |
| Oct 31, 2025 | 0.11 |
| Jul 31, 2025 | 0.09 |
| Apr 30, 2025 | 0.09 |
| Jan 31, 2025 | 0.08 |
| Oct 31, 2024 | 0.07 |
| Jul 31, 2024 | 0.09 |
| Apr 30, 2024 | 0.08 |
| Jan 31, 2024 | 0.24 |
| Oct 31, 2023 | 0.11 |
| Oct 31, 2022 | 0.46 |
API Access
enGene Therapeutics Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();